Seneca Bancorp, Inc. 10-K

Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters And Issuer Purchases Of Equity Securities Market for Seneca Bancorp’s Common Stock Seneca Bancorp’s common stock is quoted on the OTCQX Market under the trading symbol “SNNF.” Trading in the Company’s common stock commenced on October 16, 2025. As of March 1, 2026, there were 1,800,141 shares of the Company’s common stock issued and outstanding, and approximately 229 stockholders of record. Certain shares of Seneca Bancorp are held in “nominee” or “street” name and accordingly, the number of beneficial owners of such shares is not known or included in the foregoing number. The following table sets forth the quarterly high and low prices for a share of the Company’s common stock on and after October 16, 2025. The information was obtained from the OTCQX Market. The quotations reflect inter-dealer prices, without retail mark-up, markdown or commission and may not represent actual transactions. No dividends were paid in fiscal 2025. ​ ​ ​ ​ ​ ​ ​ ​ ​ Market Value of Common Stock ​ ​ ​ ​ High ​ ​ ​ Low Quarter Ended December 31, 2025 ​ $ 12.29 ​ $ 9.66 ​ Related Stockholder Matters The Company has not declared any dividends to holders of its common stock. Our Board of Directors has the authority to declare dividends on our shares of common stock, and may determine to pay dividends in the future, subject to financial condition, results of operations, tax considerations, industry standards, economic conditions, statutory and regulatory requirements that affect the payment of dividends by the Bank to the Company, and other relevant factors. No assurances can be given that any cash dividends will be paid or that, if paid, will not be reduced or eliminated in the future. Issuer Purchases of Equity Securities The Company did not purchase any shares of its common stock during the year ended December 31, 2025. Under current Federal Reserve Board regulations, the Company may not repurchase shares of its common stock during the first year following the Company’s Conversion and offering, except to fund shareholder-approved equity benefit plans or, with prior regulatory approval, when extraordinary circumstances exist. ​ Item 6. [Reserved] ​